Clinical Trial Update: Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of iron and Procrit (epoetin alfa) in patients with advanced lung cancer and chemotherapy-induced anemia has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Lung Cancer

Drugs mentioned

• Ferrous sulfate (ferrous sulfate)
• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: University of Louisville | Conditions: Anemia | Phase 2 | Status: WITHDRAWN